CN Patent

CN114667289B — 杂芳基血浆激肽释放酶抑制剂

Assigned to Takeda Pharmaceutical Co Ltd · Expires 2025-08-26 · 1y expired

What this patent protects

本发明提供了化合物及其组合物，所述化合物及其组合物可用作血浆激肽释放酶的抑制剂并且表现出血浆激肽释放酶的抑制剂的所需特性。

USPTO Abstract

本发明提供了化合物及其组合物，所述化合物及其组合物可用作血浆激肽释放酶的抑制剂并且表现出血浆激肽释放酶的抑制剂的所需特性。

Drugs covered by this patent

Patent Metadata

Patent number
CN114667289B
Jurisdiction
CN
Classification
—
Expires
2025-08-26
Drug substance claim
No
Drug product claim
No
Assignee
Takeda Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.